Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 1,810 shares at $9.00 ($16K) on 2018-09-07, disclosed to the SEC on 2018-09-11.
Scheduled sale ($16k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-07-10 | $590K | — | Filing → |
| MCRB | SELL | 2018-06-29 | $238K | — | Filing → |